Accurate target delineation is fundamental to the safe and effective delivery of radiation therapy for pancreatic cancer, particularly as dose-escalated approaches become increasingly adopted. This activity is designed to refine contouring skills for pancreatic cancer.
An estimated 90% of patients treated with radiotherapy for breast cancer will develop radiation-induced dermatitis. On the molecular level, radiation upregulates cytokine cascades and fibro-inflammatory pathways, leading to substantial fibrosis, the hallmark of chronic RT damage.
The role of radiotherapy in the management of benign diseases is ever expanding. Non-malignant entities of the head and neck are particularly complex and represent therapeutic challenges given the potential for treatment-associated morbidities.
The management of patients with nasal cavity and paranasal sinus tumors is challenging and constantly evolving. It often requires true trimodality care involving radiation oncology, otolaryngology and medical oncology, along with a variety of different supportive services.
This presentation covers the role of radiation treatment in adult patients who have newly diagnosed glioblastoma, mostly focusing on external beam radiation therapy and its use today. This session outlines the standard-of-care radiotherapy protocols, including hypofractionation schedule.
This activity discusses current evidence for radiotherapy in the management of SCLC. New phase III data combining radiation and immunotherapy (Adriatic, LU-005) is presented, with particular attention on the importance of timing of immunotherapy relative to chemoradiation.
In this upcoming webinar, participants will gain insight into a potential next frontier in advanced cranial radiosurgery: Dynamic Spherical Delivery* (DSD) — a novel under-development treatment paradigm designed to dramatically enhance treatment efficiency while expanding the boundaries of non-co
Facebook
X
LinkedIn
Forward
